# FDA recall D-1412-2014

> **Forest Pharmaceuticals Inc** · Class II · drug recall initiated 2014-06-19.

## Product

Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only.  Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.

## Reason for recall

Failed Dissolution Specifications: Drug failed stage III dissolution testing.

## Distribution

Nationwide including Puerto Rico.

## Key facts

- **Recall number:** D-1412-2014
- **Recalling firm:** Forest Pharmaceuticals Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-06-19
- **Report date:** 2014-07-09
- **Termination date:** 2016-01-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Earth City, MO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1412-2014

## Citation

> AI Analytics. FDA recall D-1412-2014. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1412-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*